The anti-inflammatory actions of IL-4 in human monocytes are not mediated by IL-10, RP105 or the kinase activity of RIPK2

Cytokine

Volumn 58, Issue 3, 2012, Pages 415-423

  Woodward, Eleanor A ^a,b   Kolesnik, Tatiana B ^c   Nicholson, Sandra E ^c   Prêle, Cecilia M ^a,d   Hart, Prue H ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b MURDOCH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Interleukin 10; Interleukin 4; Monocytes macrophages; RP105; Toll like receptor signaling

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA; NEUTRALIZING ANTIBODY; PROTEIN RP105; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 2; RECOMBINANT INTERLEUKIN 4; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR C MAF; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; C MAF GENE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME ACTIVITY; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; IL 10 GENE; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RIPK2 GENE; RP105 GENE; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, CD; BASE SEQUENCE; DNA PRIMERS; FLOW CYTOMETRY; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-4; MICE; MONOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASE 2;

MUS;

EID: 84860317491     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.03.009     Document Type: Article

References (57)

1. Hart P.H., Vitti G.F., Burgess D.R., Whitty G.A., Piccoli D.S., Hamilton J.A. Potential anti-inflammatory effects of interleukin-4. Suppression of human monocyte TNFα IL-1 and PGE2 levels. Proc Natl Acad Sci USA 1989, 86:3803-3807.
2. Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009, 27:451-483.
3. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
4. Miossec P., Chomarat P., Dechanet J., Moreau J.F., Roux J.P., Delmas P., et al. Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum 1994, 37:1715-1722.
5. Lubberts E., Joosten L.A., van Den Bersselaar L., et al. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol 1995, 163:4546-4556.
6. Clarke R.M., Lyons A., O'Connell F., Deighan B.F., Barry C.E., Anyakoha N.G., et al. A pivotal role for interleukin-4 in atorvastatin-associated neuroprotection in rat brain. J Biol Chem 2008, 283:1808-1817.
7. Aprahamian T., Bonegio R., Rizzo J., Perlman H., Lefer D.J., Rifkin I.R., et al. Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model. J Immunol 2006, 177:3028-3034.
8. Clarke C.J., Hales A., Hunt A., Foxwell B.M. IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity. Eur J Immunol 1998, 28:1719-1726.
9. Mijatovic T., Kruys V., Caput D., Defrance P., Huez G. Interleukin-4 and -13 inhibit tumor necrosis factor-alpha mRNA translational activation in lipopolysaccharide-induced mouse macrophages. J Biol Chem 1997, 272:14394-14398.
10. Donnelly R.P., Fenton M.J., Kaufman J.D., Gerrard T.L. IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4. J Immunol 1991, 146:3431-3436.
11. Donnelly R.P., Crofford L.J., Freeman S.L., Buras J., Remmers E., Wilder R.L., et al. Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-kappa B activity in monocytes and fibroblasts. J Immunol 1993, 151:5603-5612.
12. Dokter W.H., Koopmans S.B., Vellenga E. Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-kappa B) which are involved in IL-6 regulation. Leukemia 1996, 10:1308-1316.
13. Drexler S.K., Foxwell B.M. The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol 2010, 42:506-518.
14. van der Heijden I.M., Wilbrink B., Tchetverikov I., Schrijver I.A., Schouls L.M., Hazenberg M.P., et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum 2000, 43:593-598.
15. Sacre S.M., Andreakos E., Kiriakidis S., et al. The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am J Pathol 2007, 170:518-525.
16. Woodward E.A., Prêle C.M., Nicholson S.E., Kolesnik T.B., Hart P.H. The anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1). Immunology 2010, 131:118-127.
17. Varin A., Mukhopadhyay S., Herbein G., Gordon S. Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 2010, 115:353-362.
18. Hunt A.E., Williams L.M., Lali F.V., Foxwell B.M. IL-4 regulation of p38 MAPK signalling is dependent on cell type. Cytokine 2002, 18:295-303.
19. Doseff A.I., Baker J.H., Bourgeois T.A., Wewers M.D. Interleukin-4-induced apoptosis entails caspase activation and suppression of extracellular signal-regulated kinase phosphorylation. Am J Respir Cell Mol Biol 2003, 29:367-374.
20. Hart P.H., Jones C.A., Finlay-Jones J.J. Interleukin-4 suppression of monocyte tumour necrosis factor-alpha production. Dependence on protein synthesis but not on cyclic AMP production. Immunology 1992, 76:560-565.
21. Schroder A.J., Pavlidis P., Arimura A., Capece D., Rothman P.B. Cutting edge: STAT6 serves as a positive and negative regulator of gene expression in IL-4-stimulated B lymphocytes. J Immunol 2002, 168:996-1000.
22. Lehtonen A., Ahlfors H., Veckman V., Miettinen M., Lahesmaa R., Julkunen I. Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells. J Leukoc Biol 2007, 82:710-720.
23. Martinez F.O., Gordon S., Locati M., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006, 177:7303-7311.
24. Zhang S., Kim C.C., Batra S., McKerrow J.H., Loke P. Delineation of diverse macrophage activation programs in response to intracellular parasites and cytokines. PLoS Negl Trop Dis 2010, 4:e648.
25. Scotton C.J., Martinez F.O., Smelt M.J., Sironi M., Locati M., Mantovani A., et al. Transcriptional profiling reveals complex regulation of the monocyte IL-1 beta system by IL-13. J Immunol 2005, 174:834-845.
26. El Chartouni C., Rehli M. Comprehensive analysis of TLR4-induced transcriptional responses in interleukin 4-primed mouse macrophages. Immunobiology 2010, 215:780-787.
27. Stout R.D., Jiang C., Matta B., Tietzel I., Watkins S.K., Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 2005, 175:342-349.
28. Prêle C.M., Woodward E.A., Bisley J., Keith-Magee A., Nicholson S.E., Hart P.H. SOCS1 regulates the IFN but not NFkappaB pathway in TLR-stimulated human monocytes and macrophages. J Immunol 2008, 181:8018-8026.
29. Cao S., Liu J., Song L., Ma X. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J Immunol 2005, 174:3484-3492.
30. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
31. Argast G.M., Fausto N., Campbell J.S. Inhibition of RIP2/RIck/CARDIAK activity by pyridinyl imidazole inhibitors of p38 MAPK. Mol Cell Biochem 2005, 268:129-140.
32. Windheim M., Lang C., Peggie M., Plater L.A., Cohen P. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochem J 2007, 404:179-190.
33. Kobayashi K., Inohara N., Hernandez L.D., Galán J.E., Núñez G., Janeway C.A., et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002, 416:194-199.
34. Chin A.I., Dempsey P.W., Bruhn K., Miller J.F., Xu Y., Cheng G. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 2002, 416:190-194.
35. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001, 13:85-94.
36. Smolinska M.J., Horwood N.J., Page T.H., Smallie T., Foxwell B.M. Chemical inhibition of Src family kinases affects major LPS-activated pathways in primary human macrophages. Mol Immunol 2008, 45:990-1000.
37. Frevel M.A., Bakheet T., Silva A.M., Hissong J.G., Khabar K.S., Williams B.R. p38 mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol Cell Biol 2003, 23:425-436.
38. Divanovic S., Trompette A., Atabani S.F., et al. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol 2005, 6:571-578.
39. Chang E.Y., Guo B., Doyle S.E., Cheng G. Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J Immunol 2007, 178:6705-6709.
40. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991, 174:1209-1220.
41. Hamilton T.A., Ohmori Y., Tebo J.M., Kishore R. Regulation of macrophage gene expression by pro- and anti-inflammatory cytokines. Pathobiology 1999, 67:241-244.
42. Takeshita S., Gage J.R., Kishimoto T., Vredevoe D.L., Martínez-Maza O. Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. J Immunol 1996, 156:2591-2598.
43. Wang P., Wu P., Siegel M.I., Egan R.W., Billah M.M. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995, 270:9558-9563.
44. Ohmori Y., Smith M.F., Hamilton T.A. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J Immunol 1996, 157:2058-2065.
45. Ohmori Y., Hamilton T.A. STAT6 is required for the anti-inflammatory activity of interleukin-4 in mouse peritoneal macrophages. J Biol Chem 1998, 273:29202-29209.
46. Williams L., Bradley L., Smith A., Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 2004, 172:567-576.
47. Park J.H., Kim Y.G., McDonald C., Kanneganti T.D., Hasegawa M., Body-Malapel M., et al. RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol 2007, 178:2380-2386.
48. Lin Y., Yang Q., Wang X., Liu Z.G. The essential role of the death domain kinase receptor-interacting protein in insulin growth factor-I-induced c-Jun N-terminal kinase activation. J Biol Chem 2006, 281:23525-23532.
49. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., Paul W.E. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999, 17:701-738.
50. Abbott D.W., Wilkins A., Asara J.M., Cantley L.C. The Crohn' disease protein, NOD2, requires RIPK2 in order to induce ubiquitinylation of a novel site on NEMO. Curr Biol 2004, 14:2217-2227.
51. Ruschmann J., Ho V., Antignano F., et al. Tyrosine phosphorylation of SHIP promotes its proteasomal degradation. Exp Hematol 2010, 38:392-402.
52. Moreira L.O., El Kasmi K.C., Smith A.M., et al. The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced pro-inflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cell walls. Cell Microbiol 2008, 10:2067-2077.
53. Berclaz P.Y., Carey B., Fillipi M.D., et al. GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS. Am J Respir Cell Mol Biol 2007, 36:114-121.
54. Cao S., Liu J., Chesi M., Bergsagel P.L., Ho I.C., Donnelly R.P., et al. Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma. J Immunol 2002, 169:5715-5725.
55. O'Neill L.A., Sheedy F.J., McCoy C.E. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 2011, 11:163-175.
56. Lu T.X., Munitz A., Rothenberg M.E. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 2009, 182:4994-5002.
57. Bailey M.J., Lacey D.C., de Kok B.V., Veith P.D., Reynolds E.C., Hamilton J.A. Extracellular proteomes of M-CSF (CSF-1) and GM-CSF-dependent macrophages. Immunol Cell Biol 2011, 89:283-293.